Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks.
Saved in:
| Title: | Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks. |
|---|---|
| Authors: | Kehrloesser S; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK., Oberst S; Organisation of European Cancer Institutes, Brussels, Belgium.; Cancer Research UK Cambridge Centre, University of Cambridge, UK., Westerhuis W; the Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Wendler A; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK., Wind A; Rijnstate Hospital, Arnhem, The Netherlands., Blaauwgeers H; the Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Burrion JB; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Nagy P; National Institute of Oncology, Budapest, Hungary., Saeter G; Organisation of European Cancer Institutes, Brussels, Belgium.; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Gustafsson E; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden., De Paoli P; Alliance Against Cancer, Rome, Italy., Lovey J; Organisation of European Cancer Institutes, Brussels, Belgium.; National Institute of Oncology, Budapest, Hungary., Lombardo C; Organisation of European Cancer Institutes, Brussels, Belgium., Philip T; Organisation of European Cancer Institutes, Brussels, Belgium.; Institut Curie, Paris Cedex 05, France., de Valeriola D; Organisation of European Cancer Institutes, Brussels, Belgium.; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Docter M; Rijnstate Hospital, Arnhem, The Netherlands., Boomsma F; Radiotherapeutisch Instituut Friesland, Leeuwarden, The Netherlands., Saghatchian M; Institut Gustave Roussy, Villejuif, France.; American Hospital of Paris, Neuilly-sur-Seine, France., Svoboda M; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Philip I; Centre Léon Bérard, Lyon, France., Monetti F; Ospedale Policlinico San Martino, Genova, Italy., Hummel H; the Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., McVie G; Cancer Intelligence, Bristol, UK., Otter R, van Harten W; Organisation of European Cancer Institutes, Brussels, Belgium.; Rijnstate Hospital, Arnhem, The Netherlands.; The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands. |
| Source: | Molecular oncology [Mol Oncol] 2021 May; Vol. 15 (5), pp. 1277-1288. Date of Electronic Publication: 2021 Mar 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
